Oral Proteins & Peptides Market: Growth, Size, Share, and Trends
The oral proteins and peptides market is experiencing significant growth, driven by advancements in drug delivery technologies and an increasing prevalence of chronic diseases. As of 2024, the market was valued at approximately USD 7.38 billion and is projected to reach USD 20.36 billion by 2029, reflecting a compound annual growth rate (CAGR) of 22.5% during this period. Download PDF Brochure Key Market Drivers Rising Prevalence of Chronic Diseases : The increasing incidence of conditions such as diabetes, cancer, and hormonal disorders has heightened the demand for effective treatments. Oral proteins and peptides offer targeted therapeutic benefits, making them a preferred choice in managing these diseases. Advancements in Drug Delivery Technologies : Innovations in drug delivery systems, including nanoparticles, permeability enhancers, and protease inhibitors, have improved the stability and bioavailability of oral proteins and peptides. These advancements have facilit...